Youssef Bennani is the Chairman of the Board of Directors at Domain Therapeutics-France and Domain Therapeutics North America-Canada.  He is the former VP R&D-Vertex Pharmaceuticals-Canada. He holds a PhD in Chemistry from the University of Montreal, an MBA from LFGSM-Chicago and an ICD-D from McGill. His 25-year pharmaceutical experience covers various aspects of Research, early development and transactional strategies. He worked in the areas of oncology, immune disorders, neurology and infectious diseases, helping advance numerous clinical assets, and chaperoned the creation of several new R&D-ventures.